PRICE T ROWE ASSOCIATES INC /MD/ - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$356
-99.8%
16,576
+1.1%
0.00%
Q3 2022$194,000
-0.5%
16,397
+11.2%
0.00%
Q2 2022$195,000
-33.2%
14,747
+5.7%
0.00%
Q1 2022$292,000
+9.8%
13,953
+6.8%
0.00%
Q4 2021$266,000
-17.9%
13,063
+22.2%
0.00%
Q3 2021$324,000
+4.9%
10,690
+0.6%
0.00%
Q2 2021$309,000
-37.6%
10,629
-7.2%
0.00%
Q1 2021$495,000
-5.7%
11,459
+0.8%
0.00%
Q4 2020$525,00011,3710.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders